3.0.0 2564 2023-01-13T04:48:38Z 2023-01-13T04:48:38Z Senate S S 2006-04-06 109 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2006-04-06T18:36:17Z Biodefense and Pandemic Vaccine and Drug Development Act of 2006 109 5533 HR 2006-11-13 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 2006-04-06 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S3222-3227) IntroReferral 2006-04-06 Introduced in Senate IntroReferral 10000 9 Library of Congress B001135 Sen. Burr, Richard [R-NC] Richard Burr R NC Mauze N F000439 Sen. Frist, William H. [R-TN] WILLIAM FRIST R TN H. 2006-04-06 True E000285 Sen. Enzi, Michael B. [R-WY] MICHAEL ENZI R WY B. 2006-04-06 True G000445 Sen. Gregg, Judd [R-NH] Judd Gregg R NH 2006-04-06 True A000360 Sen. Alexander, Lamar [R-TN] Lamar Alexander R TN 2006-04-06 True D000601 Sen. Dole, Elizabeth [R-NC] Elizabeth Dole R NC H. 2006-04-06 True Health Access to health care Antibiotics Antitrust law Biological warfare Chemical warfare Commerce Communicable diseases Communication in medicine Congress Congressional investigations Congressional reporting requirements Department of Health and Human Services Drug industry Economic impact statements Economics and Public Finance Epidemics Executive reorganization Federal advisory bodies Federal aid to research Government Operations and Politics Government paperwork Government procurement Government trust funds Health planning Marketing Medical research Medical tests Nuclear terrorism Orphan drugs Pharmaceutical research Radiation victims Research and development Science, Technology, Communications Strategic planning Technological innovations Terrorism Vaccines Health 00 2006-04-06 Introduced in Senate 2006-06-02T20:27:12Z Biodefense and Pandemic Vaccine and Drug Development Act of 2006 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop and make public a strategic plan to integrate biodefense and emerging infectious disease requirements with the advanced research and development, strategic initiatives for innovation, and the procurement of qualified countermeasures and qualified pandemic or epidemic products.

Establishes the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services (HHS).

Requires the Secretary to: (1) coordinate and oversee the acceleration of countermeasure and product advanced research and development; and (2) delegate to the Director of BARDA any necessary functions and authorities.

Establishes the Biodefense Medical Countermeasure Development Fund.

Requires the Secretary to establish the National Biodefense Science Board to provide expert advice and guidance to the Secretary on matters relating to current and future chemical, biological, nuclear, and radiological agents.

Amends the Federal Food, Drug, and Cosmetic Act to extend the period of market exclusivity from seven years to ten years for certain new drugs, antibiotics, or anti-infective drugs to treat a rare disease or condition caused by a biological agent, toxin, chemical, radiological, or nuclear agent that is deemed by the Secretary to be a material threat to the United States.

Provides an antitrust exemption for: (1) meetings and consultations held by the Secretary among persons engaged in the development of countermeasures or pandemic or epidemic products; and (2) agreements resulting from such meetings.

Prohibits payment on a security countermeasure procurement contract until the delivery of an acceptable portion of such product to the Secretary unless advance payment is necessary to ensure the success of the project.

]]> Biodefense and Pandemic Vaccine and Drug Development Act of 2006 Display Title Biodefense and Pandemic Vaccine and Drug Development Act of 2006 Official Title as Introduced A bill to prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes. Introduced in Senate IS Short Titles as Introduced Biodefense and Pandemic Vaccine and Drug Development Act of 2006 Introduced in Senate 2006-04-06T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109s2564is/xml/BILLS-109s2564is.xml 2006-04-06 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S3222-3227) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.